Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 915-277-1 | CAS number: 32052-51-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2000-07-24 to 2000-08-31
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Version / remarks:
- (1992)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.6 (Skin Sensitisation)
- Version / remarks:
- (1996)
- Deviations:
- no
- GLP compliance:
- yes
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- A skin sensitization test according to OECD 406 has already excisted since 2000 and is sufficient for evaluation of the skin sensitisation potential of the test substance.
- Species:
- guinea pig
- Strain:
- other: Himalayan
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS:
- Strain: Himalayan (SPF quality)
- Source: RCC Ltd., Biotechnology & Animal Breeding Division, Füllinsdorf (Switzerland)
- Sex: female
- Age: approx. 7 weeks
- Weight at study initiation: 447 +/- 33 g
- Controls: 5 females (472 +/- 31 g); treatment: vehicle
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21 +/- 3 °C
- Humidity (%): 30 - 70 %
- Air changes (per hr): 15 times/hour
- Photoperiod (hrs dark / hrs light): 12 hours
- Diet: Free access Maintenance Diet for Guinea Pigs (Altromin)
- Water: Free access to tap water - Route:
- intradermal and epicutaneous
- Vehicle:
- other: corn oil
- Concentration / amount:
- 1st application: Induction 0.5 % intracutaneous
2nd application: Induction 100 % occlusive epicutaneous
3rd application: Challenge 2 % occlusive epicutaneous - Route:
- epicutaneous, occlusive
- Vehicle:
- other: corn oil
- Concentration / amount:
- 1st application: Induction 0.5 % intracutaneous
2nd application: Induction 100 % occlusive epicutaneous
3rd application: Challenge 2 % occlusive epicutaneous - No. of animals per dose:
- 5 females control group
10 females test group - Details on study design:
- ADMINISTRATION/EXPOSURE
- Preparation of test substance for induction: Within 4 hours prior to treatment, homogeneous preparation with vehicle
- Induction schedule:
Day 1: Injections
Day 3: Assessment for dermal irritation
Day 8: 48 hours occlusive patch with 0.5 ml of 100 % test substance on clipped injection sites (control animals: vehicle)
Day 10: Removal of patch and residual test substance, assessment for dermal irritation
- Injection details: 0.1 ml each at 6 positions in clipped scapular region:
2 x Freund's Complete Adjuvant (FCA) / water for injection (50:50)
2 x test substance 0.5 % in vehicle
2 x test substance 1.0 % in vehicle / FCA (50:50) pairwise administration of each solution / suspension, symmetrical to midline and from cranial
to caudal
controls: vehicle instead of test substance
- Challenge schedule:
Day 22: Two 24 hours occlusive patches (each 0.15 ml) with (a) 2 % test substance and (b) vehicle alone on one clipped flank
Day 23: Removal of patches and residual test substance
Days 24 and 25: Assessment for challenge reaction 24 and 48 hours after patch removal
- Rechallenge: no
- Positive control: alpha-hexylcinnamic aldehyde (tech. 85 %) (not more than 6 months previously)
EXAMINATIONS
- Grading system:
Irritation: Draize scores (0 / 1 / 2 / 3 / 4 each for erythema + eschar and for edema)
Challenge:
0 = no visible change
1 = discrete or patchy erythema
2 = moderate and confluent erythema
3 = moderate erythema and swelling
4 = intense erythema and swelling Animals with scores > 0 and with more severe or more persistent skin reaction than the control = sensitized
Evaluation of sensitization rate (% animals sensitized) according to 93/21/EEC
- Pilot study: Range finding: mild to moderate (for induction) and non-irritant (for challenge) concentrations
Concentration series 100 %, 50 %, 20 %, 10 %, 5 %, 2 %, 1 % and so on as far down as necessary
A) Intracuteaneous: 2 successive series of 4 concentrations each, 2 concentrations per animal, duplicate 0.1 ml injections per concentration in
clipped scapular region, assessment 24 and 48 hours after treatment
B) Epicutaneous: 3 animals with 2 concentrations per animal, 0.5 ml per concentration in 24 hours occlusive patch on clipped flank, assessment 24 and 48 hours after exposure - Challenge controls:
- 0.15 ml vehicle alone on one clipped flank
- Positive control substance(s):
- no
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 2 %
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- no
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 2 %. No with. + reactions: 0.0. Total no. in groups: 5.0. Clinical observations: no.
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 2 %
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- no
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 2 %. No with. + reactions: 0.0. Total no. in groups: 5.0. Clinical observations: no.
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 2 %
- No. with + reactions:
- 10
- Total no. in group:
- 10
- Clinical observations:
- no symptoms of systemic toxicity
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 2 % . No with. + reactions: 10.0. Total no. in groups: 10.0. Clinical observations: no symptoms of systemic toxicity.
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 2 %
- No. with + reactions:
- 10
- Total no. in group:
- 10
- Clinical observations:
- no symptoms of systemic toxicity
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 2 %. No with. + reactions: 10.0. Total no. in groups: 10.0. Clinical observations: no symptoms of systemic toxicity.
- Conclusions:
- The skin reactions observed in response to the 2 % test substance concentration in all experimental animals in the challenge phase were considered indicative of sensitation, based in the absence of any response in the control animals. The results indicate a sensitisation rate of 100 %.
- Executive summary:
The skin sensitizing properties of 2,2,4 -/2,4,4 -trimethylhexane-1,6 -diisocyanate were conducted in a guinea pig maximation test
according to OECD 406. Ten female guinea pigs were intradermally injected with a 0.5 % concentration of 2,2,4 -/2,4,4 -trimethylhexane-1,6 -diisocyanate (in corn oil) and epidermally exposed to a 100 % concentration of test substance. Five control animals were similary treated, but with vehicle alone. Two weeks after the epidermal application all animals were challenged with 2 % test substance and the vehicle. The skin reactions observed in response to the 2 % test substance concentration in all experimental animals in the challenge phase were considered indicative of sensitation, based in the absence of any response in the control animals. The results indicate a sensitisation rate of 100 %.
Reference
RESULTS OF PILOT STUDY:
A) Intracutaneous: Erythema of grades 2-4 at 0.5 and 1 %; necroses of 3-12 mm at 2-100 %
B) Epicutaneous: Erythema of grades 1-2 at 5-100 %, no edema
RESULTS OF TEST
- Sensitization reaction:
Skin reactions of grade 2 in 10/10 animals both 24 and 48 hours after removal of challenge patch. Additionally eschar formation in 10/10 animals at 48 hours reading. No skin reactions were evident in the control animals.
- Clinical signs: No mortality occurred and no symptoms of systemic toxicity were observed in the animals of the main study.
- Other: Mean body weight gain 101 g in test group, 119 g in control group = same range
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (sensitising)
- Additional information:
Migrated from Short description of key information:
The skin reactions observed in response to the 2 % test substance concentration in all experimental animals in the challenge phase were considered indicative of sensitization. There was no response in the control animals. The results indicate a sensitization rate of 100 %.
Justification for selection of skin sensitization endpoint:
key study
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
- Additional information:
Based on the fact that isocyanates are well known to cause sensitizing effects in the respiratory tract, the substance 2,2,4(or 2,4,4)-trimethylhexane-1,6 -diisocyanate is also regarded as sensitizing to the respiratory tract.
Justification for classification or non-classification
According to the criteria of EC Directive 67/548/EEC and EC Regulation 1272/2008 and subsequent regulations on classification, labelling and packaging of substances and mixtures and based on the results of the studies for 2,2,4(or 2,4,4)-trimethylhexane-1,6-diisocyanate, the test substance is classified for respiratory sensitization category 1, H334, and for skin sensitization category 1, H317.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.